These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24944395)

  • 1. Body weight loss with phentermine alone versus phentermine and fenfluramine with very-low-calorie diet in an outpatient obesity management program: a retrospective study.
    Li Z; Hong K; Yip I; Huerta S; Bowerman S; Walker J; Wang H; Elashoff R; Go VL; Heber D
    Curr Ther Res Clin Exp; 2003 Jul; 64(7):447-60. PubMed ID: 24944395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD; Dhurandhar NV; Rahko PS; Atkinson RL
    Int J Obes (Lond); 2007 May; 31(5):850-7. PubMed ID: 17146452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The longitudinal effects of fenfluramine-phentermine use.
    Fleming RM; Boyd LB
    Angiology; 2007; 58(3):353-9. PubMed ID: 17626991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
    Lew R; Weisenberg B; Vosmer G; Seiden LS
    Synapse; 1997 May; 26(1):36-45. PubMed ID: 9097403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
    Rothman RB; Elmer GI; Shippenberg TS; Rea W; Baumann MH
    Ann N Y Acad Sci; 1998 May; 844():59-74. PubMed ID: 9668665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months.
    Burger AJ; Sherman HB; Charlamb MJ; Kim J; Asinas LA; Flickner SR; Blackburn GL
    J Am Coll Cardiol; 1999 Oct; 34(4):1153-8. PubMed ID: 10520805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fen-phen finale: a study of weight loss and valvular heart disease.
    Wadden TA; Berkowitz RI; Silvestry F; Vogt RA; St John Sutton MG; Stunkard AJ; Foster GD; Aber JL
    Obes Res; 1998 Jul; 6(4):278-84. PubMed ID: 9688104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of phentermine-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m
    Ard JD; Beavers DP; Hale E; Miller G; McNatt S; Fernandez A
    Surg Obes Relat Dis; 2019 Jul; 15(7):1039-1043. PubMed ID: 31147285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phentermine and cocaine on fenfluramine-induced depletion of serotonin in mouse brain.
    Baumann MH; Schuster CR; Rothman RB
    Drug Alcohol Depend; 1996 May; 41(1):71-4. PubMed ID: 8793312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.
    Weintraub M; Sundaresan PR; Madan M; Schuster B; Balder A; Lasagna L; Cox C
    Clin Pharmacol Ther; 1992 May; 51(5):586-94. PubMed ID: 1587072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise.
    Weintraub M; Sundaresan PR; Schuster B; Ginsberg G; Madan M; Balder A; Stein EC; Byrne L
    Clin Pharmacol Ther; 1992 May; 51(5):595-601. PubMed ID: 1587073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies.
    Rea WP; Rothman RB; Shippenberg TS
    Synapse; 1998 Sep; 30(1):107-11. PubMed ID: 9704887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial weight loss as a predictor of response to obesity drugs.
    Dhurandhar NV; Blank RC; Schumacher D; Atkinson RL
    Int J Obes Relat Metab Disord; 1999 Dec; 23(12):1333-6. PubMed ID: 10643693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats.
    Roth JD; Rowland NE
    Psychopharmacology (Berl); 1998 May; 137(1):99-106. PubMed ID: 9631962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic and mitral fenfluramine-phentermine valvulopathy in 64 patients treated with anorectic agents.
    Volmar KE; Hutchins GM
    Arch Pathol Lab Med; 2001 Dec; 125(12):1555-61. PubMed ID: 11735689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography studies on the pharmacokinetics of phentermine and fenfluramine in brain and blood microdialysates after intraperitoneal administration to rats.
    Kaddoumi A; Nakashima MN; Maki T; Matsumura Y; Nakamura J; Nakashima K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):291-303. PubMed ID: 12798189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenfluramine-Phentermine (Fen-Phen) and Seizures: Evidence for an Association.
    Spencer DC; Hwang J; Morrell MJ
    Epilepsy Behav; 2000 Dec; 1(6):448-452. PubMed ID: 12737835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss and dropout during a commercial weight-loss program including a very-low-calorie diet, a low-calorie diet, or restricted normal food: observational cohort study.
    Hemmingsson E; Johansson K; Eriksson J; Sundström J; Neovius M; Marcus C
    Am J Clin Nutr; 2012 Nov; 96(5):953-61. PubMed ID: 22990030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
    Kiortsis DN
    Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.